The prevention and treatment of alcohol use disorders may benefit from interprofessional team training, according to a study.

Published Date: 22 Mar 2023

An LSU Health New Orleans study showed the value of single, focused Interprofessional Education (IPE)-based exercises in assisting young students of health professions to control or avoid alcohol use disorder (AUD).

Read Full News

Latest News

BP Med Promising as First to Modify Rare Leukodystrophy

In a phase 1/2 study, guanabenz was associated with a 67% lower risk of losing the ability to walk in children with vanishing white matter disease, a rare and devastating leukodystrophy.

Behavioral Economics May Aid Obesity Results in Primary Care

From financial incentives to ‘gamification’ of weight loss, researchers are testing ways to help patients lose weight and keep it off.

WHO chief urges clampdown on nicotine products aimed at kids

Sleek-looking disposable e-cigarettes and candy-flavored nicotine pouches are among a range of new products targeting young people and fueling a new wave of tobacco and nicotine addiction, the WHO warned Monday.

Unregulated and unsafe: Expert warns of risks in substance use reduction apps

In a commentary published by the Journal of the American Medical Association, researchers at Rutgers Health, Harvard University and the University of Pittsburgh discuss the impact of unregulated mobile health and generative ...

Detection is not prevention: Will drug testing drivers really make NZ roads safer?

The government's new mandate to carry out random oral-fluid roadside drug testing marks a milestone in New Zealand's road safety policy.

The shocking cost of inaction on alcohol in Australia

Alcohol-related diseases and injuries have the potential to cost the Australian health care system a staggering $68 billion over 60 years if nothing is done to stop the impact.

Todays Updates

Sequencing Method Flags AML Relapse Risk Around Transplant

High-sensitivity tracking of a high-risk mutation may help identify risk for relapse in patients with acute myeloid leukemia around the time of allogeneic transplant.

Todays Updates

Sequencing Method Flags AML Relapse Risk Around Transplant

High-sensitivity tracking of a high-risk mutation may help identify risk for relapse in patients with acute myeloid leukemia around the time of allogeneic transplant.

Latest News

In a phase 1/2 study, guanabenz was associated with a 67% lower risk of losing the ability to walk in children with vanishing white matter disease, a rare and devastating leukodystrophy.

From financial incentives to ‘gamification’ of weight loss, researchers are testing ways to help patients lose weight and keep it off.

Sleek-looking disposable e-cigarettes and candy-flavored nicotine pouches are among a range of new products targeting young people and fueling a new wave of tobacco and nicotine addiction, the WHO warned Monday.

In a commentary published by the Journal of the American Medical Association, researchers at Rutgers Health, Harvard University and the University of Pittsburgh discuss the impact of unregulated mobile health and generative ...

The government's new mandate to carry out random oral-fluid roadside drug testing marks a milestone in New Zealand's road safety policy.

Alcohol-related diseases and injuries have the potential to cost the Australian health care system a staggering $68 billion over 60 years if nothing is done to stop the impact.

News All Time

Taking prescription opioids for too long can be harmful. Here's how to cut back and stop

Opioids, such as oxycodone, morphine, codeine, tramadol and fentanyl, are commonly prescribed to manage pain. You might be given a prescription when experiencing pain, or after surgery or an injury.

Vaping might seem safer than smoking but your heart could tell a different story

You may have heard that vaping is the "safer" choice than smoking. But what if the very thing designed to protect your health also puts your heart at risk?

Proposed policy calls for reduced nicotine levels in cigarettes

The American Association for Cancer Research (AACR) has endorsed a federal policy that would make cigarettes far less addictive. The proposed policy by the Food and Drug Administration (FDA) sets a maximum nicotine product ...

The 'hard, slow work' of reducing overdose deaths is having an effect

Illicit drug overdoses and the deaths they cause are trending down this year, despite spikes in a handful of states, according to a Stateline analysis of data from the federal Centers for Disease Control and Prevention.

Vaping has slowed progress in cutting teen smoking in NZ—new study

Smoking rates among adults have declined in Aotearoa New Zealand over recent decades, from 18% smoking regularly in 2011/12 to 8% in 2023/24.

A path to safer painkillers: Using cryo-electron microscopy, scientists visualize how opioids engage key brain receptor

Scientists have known for decades that opioids relieve pain by binding to molecular switches in the brain called mu-opioid receptors. What they didn't know—until now—was exactly what happens next.

More than half of young adults in Australia admit to driving drunk the morning after a night out

The belief that "friends do it too" is a major factor in young adults drink-driving (driving drunk) the morning after a night out, according to a study of almost 300 Queenslanders.

People with a gambling disorder are more likely to die by suicide, research finds

Published in BJPsych Open, this is the first UK study to use routinely collected NHS data to identify factors that may predict suicide among people with gambling problems. Using anonymous health care records from Wales covering ...

Closer proximity to cannabis retail stores linked with more cannabis use but less drinking

A statewide study of more than 60,000 adult Oregonians shows that living near cannabis retail stores is associated with a greater tendency toward frequent cannabis use but a lower likelihood of heavy alcohol consumption.

Declining union membership could be making US working-classes less happy, more susceptible to drug overdoses

When fewer people belong to unions and unions have less power, the impact goes beyond wages and job security. Those changes can hurt public health and make people more unhappy.

Tobacco still top cancer killer, despite falling smoking rates

Tobacco remains the leading preventable cause of cancer death in the U.S., despite a dramatic decline in smoking, a new American Cancer Society report says.

Among youth who vape, study finds rise in daily use and difficulty quitting

Since 2019, overall rates of nicotine vaping have declined among U.S. youth, but those who continue to vape are showing signs of worsening addiction, according to new USC research.

More states eliminating insurance hurdles for opioid use disorder medications

A new study from Tulane University found that, over the past decade, more states have moved to make it easier for people with opioid use disorder to get potentially life-saving medication.

Heterosexist discrimination linked to alcohol use among LGBQ+ students of immigrant origin

Lesbian, gay, bisexual, and queer college students distressed by harassment targeting their sexuality are at a higher risk for alcohol use, especially if they are of immigrant origin. This is among the findings of a new study ...

Reward-related neurons drive risky decision-making differently in male and female rats

Some people with psychiatric conditions, including addiction and attention deficit hyperactivity disorder, struggle to control their urges or make decisions under uncertainty. In a collaboration between the University of ...

Maldives begins 'generational ban' on smoking

The Maldives began implementing a smoking ban Saturday on anyone born after January 2007, becoming the only nation with a generational prohibition on tobacco, the Health Ministry said.

Recommended News For You

Mental health risk persists years after cancer diagnosis

Specific suicidal patterns mark the highest risk.

Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma

Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients

Compared to previous estimates, a greater number of patients participate in cancer treatment trials.

Review looks at potential treatment targets in the tumor microenvironment.

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

Recommended Articles For You

Revolutionizing Cancer Care: The Promise of Early Detection and Biomarkers 

Landmark Medical Oncology Trials Redefining Early Breast Cancer Management 

Clinical Pharmacology of Drug Exposure During Long-Term Cancer Survivorship 

A Closer Look at MCV Modules: Features, Functions, and Benefits  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Morning Immunotherapy Does Not Boost Lung Cancer Survival

2.

Adopted cancer cells and the effects of their presence.

3.

Contradictory Results Are Found in Two Pembrolizumab Trials for Head and Neck Cancer.

4.

Scientists are investigating the prevention of recurrent breast cancer, which frequently results in death.

5.

What Could This Exploratory 5-Year Survival Data in Adjuvant NSCLC Treatment Mean?

1.

Understanding Bone Metastases: How Long Can Someone Live When Cancer Spreads To The Bones?

2.

Everything You Need to Know About RDW-CV: A Comprehensive Guide 

3.

Evidence-Based Pathways for Survivorship Care Planning

4.

Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments

5.

Understanding the Role of CA 19-9 in Cancer Diagnosis and Treatment

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

2.

Diagnosis and Management in Hematology

3.

Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion

4.

Breast Cancer Awareness and Early Detection

5.

"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot